NAVARA HEALTH
Functional · Hormonal · Aesthetic · Integrative
Aesthetic Injectable Procedure · Informed Consent

Neurotoxin & Dermal Filler
Informed Consent & Acknowledgment

Practice
Navara Health, PLLC
5301 Alpha Road, Suite 34, Room 21
Dallas, Texas 75240
Contact
469-653-3124
contact@navarahealthtx.com
Treating Provider / Delegating APRN
Jessica Boggs, MSN, APRN, FNP-C, ENP-C
Aesthetic RN Injector
Rocio Gonzalez, RN
Injects under APRN delegation & GFE oversight
Medical Director
Simal Patel, MD
Texas BON / TMB Compliance
Good Faith Exam completed prior to injection
Written delegation & standing orders on file
Service Location
Dallas, Texas (In-Clinic Only · Adults 18+)

Purpose of This Consent

This is a procedure-specific informed consent for injectable neurotoxin and dermal filler treatments. It is in addition to, and where it conflicts, controls over, the Navara Health General Aesthetic Informed Consent.

Two product categories are covered by this consent: (1) Neurotoxins — botulinum toxin products that relax muscle activity, and (2) Dermal Fillers — hyaluronic acid (HA) and other injectable products that restore volume and contour. The risk profiles of these two product categories are different and are addressed separately below.

Authorization for Treatment & Provider Identification

I authorize the following clinicians at Navara Health, PLLC to evaluate me and perform neurotoxin and/or dermal filler injections as clinically appropriate:

I understand and agree that:

Products & Treatment Description

Category A · Neurotoxins
Botulinum Toxin Type A

FDA-approved products that temporarily relax targeted muscles to soften dynamic wrinkles and prevent new lines. Common uses: glabellar lines ("11s"), forehead lines, crow's feet, bunny lines, lip flip, masseter (jaw slimming and bruxism), platysmal bands, neck lift, hyperhidrosis, gummy smile, chin dimpling.

Category B · Dermal Fillers
Injectable Soft Tissue Fillers

FDA-approved hyaluronic acid (HA) fillers and other biostimulators used to restore volume, contour facial features, and improve fine lines, folds, and asymmetries. Common areas: lips, cheeks, midface, jawline, chin, tear troughs, nasolabial folds, marionette lines, perioral lines, hands.

Products Used at Navara Health

ProductTypeCommon Uses
Botox® / Botox® CosmeticNeurotoxin (onabotulinumtoxinA)Dynamic lines, hyperhidrosis
Dysport®Neurotoxin (abobotulinumtoxinA)Dynamic lines, faster onset
Xeomin®Neurotoxin (incobotulinumtoxinA)Dynamic lines, "naked" formulation
Jeuveau®Neurotoxin (prabotulinumtoxinA)Dynamic lines
Letybo®Neurotoxin (letibotulinumtoxinA)Glabellar lines
Daxxify®Neurotoxin (daxibotulinumtoxinA)Dynamic lines, longer duration
Juvéderm® familyHA fillerLips, cheeks, folds, midface, jaw
Restylane® familyHA fillerLips, tear troughs, midface, hands
RHA® collectionHA filler (resilient)Dynamic areas, perioral
Belotero®HA filler (fine lines)Perioral, superficial lines

I understand that the specific product, dose (units for neurotoxin or mL for filler), and injection sites will be selected by my injector based on my anatomy, goals, and clinical judgment, and will be discussed with me prior to injection.

Expected Results & Onset / Duration

Neurotoxins

Typical Duration by Product

FDA Approval & On-Label vs. Off-Label Use

Treatment Continuity

Dermal Fillers

Results are not guaranteed. Individual response, anatomy, metabolism, and lifestyle (sun, smoking, exercise intensity, hormonal factors) affect both visible result and longevity.

Risks & Possible Complications — Neurotoxins

Common / Expected
Injection-Site Effects
Mild pain or pinch at injection. Pinpoint bleeding. Bruising. Redness or small bumps at injection sites resolving within minutes to hours. Mild headache (especially first treatment). Tightness or "heavy" sensation.
Less Common
Functional & Cosmetic
Eyelid ptosis (drooping eyelid) typically 1–4 weeks duration. Brow ptosis or asymmetric brow position ("Spock brow"). Asymmetric smile or mouth movement. Dry eye, watery eye, or blurred vision. Difficulty making certain expressions. Flu-like symptoms or mild nausea. Allergic or sensitivity reaction. Antibody formation reducing future response.
Rare but Serious
Significant Risks
Anaphylaxis or severe allergic reaction. Distant spread of toxin effect (see emergency callout below). Worsening of underlying neuromuscular disease (myasthenia gravis, Lambert-Eaton, ALS). Cardiovascular events (very rare).
FDA Boxed Warning · Distant Spread of Toxin Effect

All botulinum toxin products — including Botox®, Dysport®, Jeuveau®, Xeomin®, Letybo®, and Daxxify® — carry a risk of spread of toxin effect beyond the injection site. Symptoms may occur hours, days, or weeks after injection and may include:

Swallowing or breathing difficulties may be life-threatening and require emergency medical care. If these symptoms occur, call 911 immediately, then notify Navara Health.

Risks & Possible Complications — Dermal Fillers

Common / Expected
Injection-Site Effects
Swelling, redness, bruising, tenderness, or itching at injection sites — typically resolves within days to 2 weeks. Lumps or palpable product that softens as it integrates. Asymmetry that often resolves with swelling. Discomfort with chewing or facial expressions.
Less Common
Product-Related Complications
Persistent nodules or palpable lumps. Migration of product to unintended areas. Tyndall effect (bluish discoloration in thin skin, especially tear troughs). Prolonged swelling or erythema. Delayed inflammatory or immune reactions (sometimes weeks to months later, including after illness, vaccination, or dental work). Hypersensitivity reaction. Granuloma formation. Infection. Reactivation of cold sores (herpes simplex) — prophylactic antiviral may be advised for patients with a history.
Rare but Serious
Vascular Complications
Vascular occlusion (blood vessel blockage), tissue ischemia, skin necrosis, scarring. Blindness or permanent visual disturbance from accidental intra-arterial injection — documented in the medical literature, most commonly with injections near the glabella, nose, forehead, nasolabial folds, and tear troughs. Stroke or cerebrovascular event. Severe allergic reaction or anaphylaxis. Hematoma. Ulceration or tissue erosion. Nerve injury or prolonged numbness. Long-term cosmetic distortion requiring corrective procedures.
Vascular Occlusion is a Medical Emergency

Vascular occlusion can occur even with proper technique. Emergency corrective interventions — including hyaluronidase administration, warm compresses, massage, nitroglycerin paste, aspirin, antibiotics, and/or referral for emergency or specialty care — may be required.

These interventions may involve additional cost that is my financial responsibility. Hyaluronidase reversal carries its own risks (allergic reaction, dissolution of desired filler) and is only effective for HA-based fillers.

Contraindications & Precautions

I should not receive neurotoxin or filler treatment, or treatment may be delayed/modified, if I have or disclose:

Pre- and Post-Procedure Responsibilities

Before Treatment

After Neurotoxin

After Dermal Filler

Call Navara Health Immediately for

For life-threatening symptoms (vision loss, stroke symptoms, anaphylaxis), call 911 first, then notify Navara Health.

Off-Label Use Disclosure

Some neurotoxin and filler uses are off-label, meaning they have not received specific FDA approval for that indication, even though the product is FDA-approved for other uses. Off-label use is legal, common, and accepted in aesthetic medicine and is at the provider's clinical discretion. Examples include:

Financial Disclosure

I understand and agree that:

Communication & HIPAA Authorization

I authorize Navara Health to communicate with me regarding scheduling, pre/post-procedure instructions, follow-up, and adverse event reporting through:

I understand that email and SMS are not fully secure channels. I may revoke authorization for any specific channel in writing to contact@navarahealthtx.com, except where required for legally mandated notices.

Assumption of Risk & Release of Liability

I voluntarily assume all known and unknown risks associated with neurotoxin and dermal filler treatment. To the fullest extent permitted by law, I agree to release, indemnify, and hold harmless Navara Health, PLLC, Jessica Boggs APRN, Rocio Gonzalez RN, the medical director, and all affiliated providers, nurses, contractors, and staff from liability related to:

This release does not apply to cases of gross negligence or willful misconduct, and does not waive any right that cannot lawfully be waived under the laws of the State of Texas.

Dispute Resolution & Binding Arbitration

Any dispute, controversy, or claim arising out of or relating to this Consent, the procedure performed, or the practitioner-patient relationship — including any claim of medical malpractice, billing dispute, or breach of contract — shall first be addressed by good-faith negotiation between the parties.

If the matter cannot be resolved through negotiation within thirty (30) days, the parties agree to submit the dispute to binding arbitration administered by a recognized arbitration body (such as the American Arbitration Association) under its applicable rules, with the arbitration to take place in Dallas County, Texas.

The parties acknowledge that by agreeing to arbitration, they are waiving the right to a jury trial. This provision does not waive any right that cannot lawfully be waived under Texas law. Either party retains the right to seek injunctive or equitable relief in court where appropriate.

Governing Law & Severability

This Consent shall be governed by and construed under the laws of the State of Texas. If any provision is found unenforceable, the remaining provisions shall remain in full force and effect.

Photography & Marketing Authorization

Photographs taken before, during, and after injectable treatments serve different purposes, and I am being asked to provide separate consent for each use. I understand I may consent to medical documentation while declining marketing use, or vice versa.

Photography Use — Please Initial Each Option

Required · Medical Documentation I consent to clinical photographs of the treatment area being taken before, during, and after services for the purpose of medical documentation, treatment planning, and inclusion in my confidential medical record. These photographs will not be shared outside the practice without further written authorization.
Optional · Marketing & Promotional Use I additionally authorize Navara Health, PLLC to use my before/after photographs in marketing materials, including the practice website, social media (Instagram, Facebook, TikTok, etc.), printed materials, advertisements, and educational content. My face may be identifiable in these images. No compensation will be provided. I may revoke this authorization at any time in writing, and Navara Health will stop using the images going forward, though I understand previously published images cannot always be recalled from third parties or the internet.
Optional · De-Identified Marketing Use Only I authorize use of my before/after photographs in marketing materials only with my face de-identified (eyes/identifying features cropped or obscured). I do not authorize identifiable images for marketing.
Optional · Provider Education & Conferences I authorize use of my before/after photographs (identifiable or de-identified, as initialed above) in professional education contexts, including conferences, clinician training, peer education, and published case reports.
Patient Signature (Photography & Marketing)
Date

Patient Initials — Required for Each Critical Clause

Each of the following clauses requires my separate written initials. By initialing, I confirm that I understand and agree to each individual clause.
I understand that injection may be performed by Rocio Gonzalez, RN under APRN delegation, and that a Good Faith Exam by Jessica Boggs, APRN has been or will be completed.
Initials
I understand the specific risks of vascular occlusion, tissue ischemia, scarring, and rare but documented vision loss with dermal filler, and I accept these risks.
Initials
I understand the FDA boxed warning regarding distant spread of neurotoxin effect and the risk of generalized muscle weakness, swallowing, or breathing difficulty (extremely rare).
Initials
I understand that emergency corrective treatments (including hyaluronidase) may be required at additional cost if a filler complication occurs.
Initials
I understand that no refunds are issued once a syringe is opened or any product is injected.
Initials
I will wait at least 14 days after neurotoxin and 2–4 weeks after filler before requesting touch-ups or assessing final results.
Initials
I agree to binding arbitration as described in Section 12 and understand that I am waiving the right to a jury trial.
Initials

Patient Acknowledgment & Electronic Consent

By signing below (or by typing my full legal name as an electronic signature), I acknowledge and affirm:

Patient Printed Name
Date of Birth
Treatment Type (Neurotoxin / Filler / Both)
Date
Patient Signature (or Typed Electronic Signature)
Date
Injector Signature (Jessica Boggs, APRN or Rocio Gonzalez, RN)
Date
Delegating APRN Signature (Jessica Boggs, APRN) — GFE Completed
Date